1. 2018
  2. Use of Nanobodies for medical applications and activities of the spin-off company Camel-IDS

    Matthias D'Huyvetter (Speaker)
    10 Aug 2018

    Activity: Talk or presentationTalk or presentation at a workshop/seminar

  3. Targeted Radionuclide Therapy with Nanobodies

    Matthias D'Huyvetter (Speaker)
    23 Apr 201827 Apr 2018

    Activity: Talk or presentationTalk or presentation at a workshop/seminar

  4. An 131I-labeled camelid single-domain antibody fragment to treat HER2-overexpressing cancer

    Matthias D'Huyvetter (Contributor), Jens De Vos (Contributor), Catarina Xavier (Contributor), Marek Pruszynski (Contributor), Yann Sterckx (Contributor), Sam Massa (Contributor), Geert Raes (Contributor), Vicky Caveliers (Contributor), Michaël Zalutsky (Contributor), Tony Lahoutte (Contributor), Nick Devoogdt (Speaker)
    21 Mar 2018

    Activity: Talk or presentationTalk or presentation at a conference

  5. 2017
  6. Preclinical evaluation of astatinated nanobodies for targeted alpha therapy

    Yana Dekempeneer (Speaker), Matthias D'Huyvetter (Contributor), Catarina Xavier (Contributor), Tony Lahoutte (Contributor), Vicky Caveliers (Contributor)
    22 Oct 2017

    Activity: Talk or presentationTalk or presentation at a conference

  7. Towards targeted alpha therapy using 213Bi-labeled nanobodies

    Yana Dekempeneer (Speaker), Tony Lahoutte (Contributor), Matthias D'Huyvetter (Contributor), Vicky Caveliers (Contributor)
    22 Oct 2017

    Activity: Talk or presentationTalk or presentation at a conference

  8. Nanobodies for Cancer Treatment.

    Matthias D'Huyvetter (Speaker)
    7 Sep 2017

    Activity: Talk or presentationTalk at an external academic organisation

  9. Nanobodies for cancer treatment

    Matthias D'Huyvetter (Invited speaker)
    7 Sep 2017

    Activity: Talk or presentationTalk or presentation at a workshop/seminar

  10. Astatinated nanobodies, a promising new treatment approach in targeted alpha therapy

    Yana Dekempeneer (Speaker), Matthias D'Huyvetter (Contributor), Emma Aneheim (Contributor), Catarina Xavier (Contributor), Tony Lahoutte (Contributor), Tom Bäck (Contributor), Holger Jensen (Contributor), Vicky Caveliers (Contributor), Sture Lindgren (Contributor)
    29 May 2017

    Activity: Talk or presentationTalk or presentation at a conference

  11. Preclinical evaluation of anti-HER2 2Rs15d nanobody labeled with 225Ac

    Marek Pruszynski (Speaker), Matthias D'Huyvetter (Contributor), E Cedrowska (Contributor), Tony Lahoutte (Contributor), F Bruchertseifer (Contributor), A Morgenstern (Contributor)
    29 May 20172 Jun 2017

    Activity: Talk or presentationTalk or presentation at a conference

  12. Sortase as a tool to produce Nanobody based radiopharmaceuticals for theranostics

    Maxine Crauwels (Speaker), Sam Massa (Contributor), Cecilia Betti (Contributor), Charlotte Martin (Contributor), Steven Ballet (Contributor), Matthias D'Huyvetter (Contributor), Sophie Hernot (Contributor), Vicky Caveliers (Contributor), Tony Lahoutte (Contributor), Nick Devoogdt (Contributor), Serge Muyldermans (Contributor), Catarina Xavier (Contributor)
    18 May 2017

    Activity: Talk or presentationTalk or presentation at a conference

Previous 1 2 3 Next

ID: 118617